Direct comparisons of three alternative plasma fibrinogen assays with the Von Clauss assay in prediction of cardiovascular disease and all-causes mortality: the Scottish heart health extended cohort

Sanne A.E. Peters, Mark Woodward, Ann Rumley, Wolfgang Koenig, Hugh Tunstall-Pedoe, Gordon D. O. Lowe (Lead / Corresponding author)

    Research output: Contribution to journalArticle

    11 Citations (Scopus)

    Abstract

    There is strong evidence from meta-analyses of prospective epidemiological studies that increasing plasma fibrinogen levels are associated with an increasing risk of cardiovascular disease (CVD) and all-cause mortality. However, there are few published direct comparisons of the several different available fibrinogen assays in association with CVD or mortality. We therefore prospectively compared the standardized von Clauss assay of clottable fibrinogen with three other assays: prothrombin time (PT)-derived clottable fibrinogen, immunonephelometric fibrinogen, and heat precipitable fibrinogen in the Scottish Heart Health Extended Cohort. Hazard ratios (HRs) for a standard deviation increase in fibrinogen for risk of CVD, adjusted for age and sex, were 1·17 (95% confidence interval [CI] 1·14; 1·21) for the von Clauss assay; 1·19 (1·06; 1·33) for the heat precipitation assay; 1·16 (1·01; 1·35) for the PT-derived assay; and 1·28 (1·10; 1·51) for the immunonephelometric assay. HRs for all-cause mortality were 1·21 (1·18; 1·24); 1·13 (1·01; 1·26), 1·17 (1·00; 1·37) and 1·17 (0·99; 1·39), respectively. No significant differences were observed between the assays in such comparisons. We therefore conclude that the choice between plasma fibrinogen assays in routine clinical haematology and biochemistry laboratories should depend on practical factors, and not on expected differences in the strength of associations.
    Original languageEnglish
    Pages (from-to)392-399
    Number of pages8
    JournalBritish Journal of Haematology
    Volume162
    Issue number3
    DOIs
    Publication statusPublished - Aug 2013

    Fingerprint

    Fibrinogen
    Cardiovascular Diseases
    Mortality
    Health
    Prothrombin Time
    Hot Temperature
    Hematology
    Biochemistry
    Meta-Analysis
    Epidemiologic Studies
    Prospective Studies
    Confidence Intervals

    Cite this

    @article{53463bdf483849879b730ca7a5afa171,
    title = "Direct comparisons of three alternative plasma fibrinogen assays with the Von Clauss assay in prediction of cardiovascular disease and all-causes mortality: the Scottish heart health extended cohort",
    abstract = "There is strong evidence from meta-analyses of prospective epidemiological studies that increasing plasma fibrinogen levels are associated with an increasing risk of cardiovascular disease (CVD) and all-cause mortality. However, there are few published direct comparisons of the several different available fibrinogen assays in association with CVD or mortality. We therefore prospectively compared the standardized von Clauss assay of clottable fibrinogen with three other assays: prothrombin time (PT)-derived clottable fibrinogen, immunonephelometric fibrinogen, and heat precipitable fibrinogen in the Scottish Heart Health Extended Cohort. Hazard ratios (HRs) for a standard deviation increase in fibrinogen for risk of CVD, adjusted for age and sex, were 1·17 (95{\%} confidence interval [CI] 1·14; 1·21) for the von Clauss assay; 1·19 (1·06; 1·33) for the heat precipitation assay; 1·16 (1·01; 1·35) for the PT-derived assay; and 1·28 (1·10; 1·51) for the immunonephelometric assay. HRs for all-cause mortality were 1·21 (1·18; 1·24); 1·13 (1·01; 1·26), 1·17 (1·00; 1·37) and 1·17 (0·99; 1·39), respectively. No significant differences were observed between the assays in such comparisons. We therefore conclude that the choice between plasma fibrinogen assays in routine clinical haematology and biochemistry laboratories should depend on practical factors, and not on expected differences in the strength of associations.",
    author = "Peters, {Sanne A.E.} and Mark Woodward and Ann Rumley and Wolfgang Koenig and Hugh Tunstall-Pedoe and Lowe, {Gordon D. O.}",
    year = "2013",
    month = "8",
    doi = "10.1111/bjh.12389",
    language = "English",
    volume = "162",
    pages = "392--399",
    journal = "British Journal of Haematology",
    issn = "0007-1048",
    publisher = "Wiley",
    number = "3",

    }

    Direct comparisons of three alternative plasma fibrinogen assays with the Von Clauss assay in prediction of cardiovascular disease and all-causes mortality : the Scottish heart health extended cohort. / Peters, Sanne A.E.; Woodward, Mark; Rumley, Ann; Koenig, Wolfgang; Tunstall-Pedoe, Hugh; Lowe, Gordon D. O. (Lead / Corresponding author).

    In: British Journal of Haematology, Vol. 162, No. 3, 08.2013, p. 392-399.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Direct comparisons of three alternative plasma fibrinogen assays with the Von Clauss assay in prediction of cardiovascular disease and all-causes mortality

    T2 - the Scottish heart health extended cohort

    AU - Peters, Sanne A.E.

    AU - Woodward, Mark

    AU - Rumley, Ann

    AU - Koenig, Wolfgang

    AU - Tunstall-Pedoe, Hugh

    AU - Lowe, Gordon D. O.

    PY - 2013/8

    Y1 - 2013/8

    N2 - There is strong evidence from meta-analyses of prospective epidemiological studies that increasing plasma fibrinogen levels are associated with an increasing risk of cardiovascular disease (CVD) and all-cause mortality. However, there are few published direct comparisons of the several different available fibrinogen assays in association with CVD or mortality. We therefore prospectively compared the standardized von Clauss assay of clottable fibrinogen with three other assays: prothrombin time (PT)-derived clottable fibrinogen, immunonephelometric fibrinogen, and heat precipitable fibrinogen in the Scottish Heart Health Extended Cohort. Hazard ratios (HRs) for a standard deviation increase in fibrinogen for risk of CVD, adjusted for age and sex, were 1·17 (95% confidence interval [CI] 1·14; 1·21) for the von Clauss assay; 1·19 (1·06; 1·33) for the heat precipitation assay; 1·16 (1·01; 1·35) for the PT-derived assay; and 1·28 (1·10; 1·51) for the immunonephelometric assay. HRs for all-cause mortality were 1·21 (1·18; 1·24); 1·13 (1·01; 1·26), 1·17 (1·00; 1·37) and 1·17 (0·99; 1·39), respectively. No significant differences were observed between the assays in such comparisons. We therefore conclude that the choice between plasma fibrinogen assays in routine clinical haematology and biochemistry laboratories should depend on practical factors, and not on expected differences in the strength of associations.

    AB - There is strong evidence from meta-analyses of prospective epidemiological studies that increasing plasma fibrinogen levels are associated with an increasing risk of cardiovascular disease (CVD) and all-cause mortality. However, there are few published direct comparisons of the several different available fibrinogen assays in association with CVD or mortality. We therefore prospectively compared the standardized von Clauss assay of clottable fibrinogen with three other assays: prothrombin time (PT)-derived clottable fibrinogen, immunonephelometric fibrinogen, and heat precipitable fibrinogen in the Scottish Heart Health Extended Cohort. Hazard ratios (HRs) for a standard deviation increase in fibrinogen for risk of CVD, adjusted for age and sex, were 1·17 (95% confidence interval [CI] 1·14; 1·21) for the von Clauss assay; 1·19 (1·06; 1·33) for the heat precipitation assay; 1·16 (1·01; 1·35) for the PT-derived assay; and 1·28 (1·10; 1·51) for the immunonephelometric assay. HRs for all-cause mortality were 1·21 (1·18; 1·24); 1·13 (1·01; 1·26), 1·17 (1·00; 1·37) and 1·17 (0·99; 1·39), respectively. No significant differences were observed between the assays in such comparisons. We therefore conclude that the choice between plasma fibrinogen assays in routine clinical haematology and biochemistry laboratories should depend on practical factors, and not on expected differences in the strength of associations.

    UR - http://www.scopus.com/inward/record.url?scp=84880290086&partnerID=8YFLogxK

    U2 - 10.1111/bjh.12389

    DO - 10.1111/bjh.12389

    M3 - Article

    C2 - 23701042

    AN - SCOPUS:84880290086

    VL - 162

    SP - 392

    EP - 399

    JO - British Journal of Haematology

    JF - British Journal of Haematology

    SN - 0007-1048

    IS - 3

    ER -